BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 32405753)

  • 21. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
    Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
    Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.
    Lim C; Salloum C; Chalaye J; Lahat E; Costentin CE; Osseis M; Itti E; Feray C; Azoulay D
    HPB (Oxford); 2019 Jun; 21(6):739-747. PubMed ID: 30401520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
    Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
    Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
    Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
    Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of the signal intensity of peritumoral tissue on Gd-EOB-DTPA dynamic enhanced MRI in assessment of microvascular invasion and pathological grade of hepatocellular carcinoma.
    Wang LL; Li JF; Lei JQ; Guo SL; Li JK; Xu YS; Dou Y
    Medicine (Baltimore); 2021 May; 100(20):e25804. PubMed ID: 34011043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
    Kim YI; Paeng JC; Cheon GJ; Suh KS; Lee DS; Chung JK; Kang KW
    J Nucl Med; 2016 Jul; 57(7):1045-51. PubMed ID: 26985057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
    Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
    Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
    Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
    Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
    Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined early dynamic
    Zhang Y; Dong Y; Yu W; Chen S; Yu H; Li B; Shi H
    Abdom Radiol (NY); 2023 Oct; 48(10):3127-3134. PubMed ID: 37439840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
    Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
    Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
    Bonatti M; Valletta R; Zamboni GA; Lombardo F; Senoner M; Simioni M; Schifferle G; Bonatti G
    Eur Radiol; 2019 Jun; 29(6):2830-2836. PubMed ID: 30643946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
    Wu TH; Hatano E; Yamanaka K; Seo S; Taura K; Yasuchika K; Fujimoto Y; Nitta T; Mizumoto M; Mori A; Okajima H; Kaido T; Uemoto S
    Surg Today; 2016 Nov; 46(11):1275-81. PubMed ID: 26983710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma: A STROBE-compliant article.
    Shin SK; Kim YS; Shim YS; Choi SJ; Park SH; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Aug; 96(33):e7761. PubMed ID: 28816953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
    Grazioli L; Morana G; Caudana R; Benetti A; Portolani N; Talamini G; Colombari R; Pirovano G; Kirchin MA; Spinazzi A
    Invest Radiol; 2000 Jan; 35(1):25-34. PubMed ID: 10639033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
    Rong D; Liu W; Kuang S; Xie S; Chen Z; Chen F; Xie Q; Luo Q; He B; Zhang Y; Deng Y; Yang H; Chen S; Wang J
    Eur Radiol; 2021 Oct; 31(10):7584-7593. PubMed ID: 33860826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.